Program
NH102
A development code.
Its studies are mostly in Depression · Depressive Disorder, Major, led by Jiangsu Nhwa Pharmaceutical.
Furthest: phase 2, since Feb 16, 20253 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Jiangsu Nhwa Pharmaceutical | 30 open or running | phase 2since Feb 16, 2025 | Aug 19, 2021 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Aug 19, 2021First study: phase 1 study in DepressionFirst studyNCT05015192 · 55 enrolled · China
- Feb 16, 2025Phase 2 study in Depressive Disorder, MajorNCT06842992 · 243 enrolled · China
- Dec 10, 2025Phase 1 study in DepressionNCT07324408 · 40 enrolled · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07324408Depression · China | 1 | Completed | Apr 10, 2023 | 40 |
| NCT06842992Depressive Disorder, Major · China | 2 | Completed | Jul 30, 2025 | 243 |
| NCT05015192Depression · China | 1 | Completed | Jan 11, 2022 | 55 |
How it is read
Names in the registry
- “NH102”, 5 entries
Codes read as this program: NH102.
Conditions, from the studies’ own filings
- Depression, 2 studies
- Depressive Disorder, Major, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.